期刊文献+

临床药师参与1例曲妥珠单抗致不良反应治疗方案的制定 被引量:2

Participation of Clinical Pharmacists in the Treatment of One Case of Adverse Reaction Induced by Trastuzumab
下载PDF
导出
摘要 目的:探索临床药师参与药物治疗方案的制定。方法:临床药师开展药学查房,通过对1名乳腺癌术后化疗继发肺炎患者询问用药史,考虑由曲妥珠单抗引起的非感染性肺浸润可能性大,结合药品说明书、相关文献及个案报道,及时向医师提出用药建议,参与患者药物治疗方案的制定。结果:医师采纳临床药师意见患者在使用甲泼尼龙琥珀酸钠后第2日,症状好转影像学检查也趋于好转,未再复发。结论:临床药师参与临床用药方案的制定,对于提高临床治疗水平具有重要意义。 Objective : To explore the participation of clinical pharmacists in drug treatment. Methods: Clinical pharmacists car- fled out pharmaceutical ward round, and understood the medication history of one breast cancer patient with postoperative pneumonia. They thought the induction possibility of trastuzumab likely to be non infectious pulmonary infiltration. Combined with the drug instruc- tions, relevant literatures and case report, they put forward suggestions for the medication, and participated in the formulation of drug therapy. Results: The suggestions of clinical pharmacists were adopted, and on the second day of methylprednisolone sodium succinate treatment, the symptoms of the patient were improved, and the results of the imaging examination also tended to be improved without recurrence. Conclusion: The participation of clinical pharmacists in the formulation of clinical medication has important significance for improving the level of clinical treatment.
作者 董利森 刘璐
出处 《中国药师》 CAS 2015年第12期2112-2113,2116,共3页 China Pharmacist
关键词 临床药师 曲妥珠单抗 非感染性肺炎 治疗方案 药学监护 合理用药 Clinical pharmacists Trastuzumab Non infectious pneumonia Treatment Pharmaceutical care Rational drug use
  • 相关文献

参考文献11

  • 1Joseph RC, Charles LS, Andrea N, et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors : cardiac and pulmonary late effects[ J ]. J Clin Oncol,2007, 25:3991-4008. 被引量:1
  • 2吴凡,陈强,叶韵斌.HER2单抗曲妥珠单抗耐药机制研究进展[J].中国新药与临床杂志,2008,27(1):60-64. 被引量:3
  • 3陈炅,尹笋君.治疗性单克隆抗体的作用靶点及临床应用概述[J].中国药师,2013,16(12):1930-1933. 被引量:5
  • 4Maajid MP,Timothy PS , Hamed AD. Pulmonary toxieities of biolog- ics:a review[J]. Anti-Cancer Drugs,2010,21:131 - 139. 被引量:1
  • 5Bobbak V, Paul EM. Pulmonary complications of novel antineoplastie agents for solid tum9rs[J]. Chest ,2008,133:528-538. 被引量:1
  • 6Hyo JK,Jong SP,Dong WK,et al. Adverse pulmonary reactions asso- ciated with the use of monoelonal antibodies in cancer patients [ J ]. Respir Meal,2012,106:443-450. 被引量:1
  • 7Radzikowska E, Szczepulska E, Chabowski M, et al. Organiaing pneumonia caused by transtuzumab (Hereeptin) therapy for breast cancer[ J]. Eur Respir J, 2003,21:552-555. 被引量:1
  • 8Omalkhair A, Wad EM. Delayed paclitaxel-trastuzumab-indueed in- terstitial pneumonitis in breast cancer[ J ]. Case Rep 0ncol,2011,4: 186-191. 被引量:1
  • 9Alvam TG, Albert SF,Sbnia ST,et aL Organizing Pneumonia Associ- ated with the Use of Trastuzumab [ J ]. Arch Bronconeumol, 2010,46 (8) :442-444. 被引量:1
  • 10刘又宁.肺真菌感染值得注意的几个问题[J].中华结核和呼吸杂志,2007,30(11):801-801. 被引量:11

二级参考文献71

共引文献129

同被引文献15

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部